
Clinical-stage biopharmaceutical company AC Immune announced that the US Food and Drug Administration (FDA) has granted its Alzheimer’s disease (AD) …

It is a research breakthrough that has been touted as the biggest development in Alzheimer’s disease research for a quarter …

